Bayer May Face Canadian Class Action Over Trasylol
Already facing dozens of suits in the U.S. over Trasylol, Bayer AG has now been hit with a proposed class action in Canada over the blood-clotting drug, which some studies have...To view the full article, register now.
Already a subscriber? Click here to view full article